Founded in 2019, Galixir aspires to be an engine to fuel up the whole pharmaceutical industry leveraging our world-leading AI technologies.

We offer pharmaceutical companies with accesses to faster and better drug discovery methods, as well as strong patent protections on drugs. Our technologies are based on cutting-edge artificial intelligence, chemical engineering, computational biology and cloud computing. With the help of Galixir AI, time and cost associated with discoveries of new medical treatments would be greatly reduced, and new solutions to originally-incurable diseases could come to patients early than ever.